During the fourth quarter, Larry Robbins’ 13F indicates significant fresh additions to the billionaire investor’s portfolio. Glenview Capital Management’s founder and CEO is Larry Robbins. As of August 24, 2021, the New York-based hedge fund had $6.13 billion in assets. Robbins moved up to 13th position on the list of top-earning money managers after the fund returned 21.1 percent last year. By the end of 2021, Glenview Capital’s 13F assets had dropped to $4.69 billion, down from $6.05 billion in the middle of 2019. 42 of the fund’s positions were sold or reduced in size, while 22 were purchased or increased in size.
Insider Monkey took a look at the top 9 stocks billionaire Larry Robbins just added to his portfolio. During the fourth quarter, Evolus, Inc. added 400 new customer accounts for their revolutionary facial wrinkles therapy, Jeuveau. Evolus’ net revenue increased by 76 percent in 2021, and the business expects further growth of 43 percent to 50 percent. The fourth-quarter acquisition of product cloud business EVRYTHNG Limited by Digimarc Corp enhanced the company’s product identification capabilities. The company’s operating loss of $8.2 million during the quarter was $1.1 million higher than its sales. In 2022, Evolv Technologies Holdings Inc has lost another 41.7 percent of its value. Recent guidance and initiatives from the security firm have left investors with more concerns than answers. This year, Evolv expects to lose between $82 million and $84 million in operating losses. Another potential buy-low candidate is Hyperfine, Inc. In a $580 million merger, Hyperfine combined with Liminal Sciences and HealthCor Catalio. Swoop, the company’s MRI-on-wheels, received FDA approval for non-contrast scans in 2020. For more details, click the Top 9 Stocks Billionaire Larry Robbins Just Added To His Portfolio.
